Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04301193 · ClinicalTrials.gov registry record
Evaluation of Novel Point of Care Coagulation System in Pregnant Women
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 13
- Enrollment target
NCT04301193 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 13 participants.
The verdict
NCT04301193 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
In this study the investigators will evaluate a new point of care Quantra Hemostasis Analyzer system to assess coagulation rapidly with ease.
Interventions
- DEVICE Quantra Analyzer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2020-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04301193
The ClinicalTrials.gov registry entry for NCT04301193 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quantra Analyzer is the first listed.
NCT04301193 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04301193 about?
NCT04301193 is a clinical study titled "Evaluation of Novel Point of Care Coagulation System in Pregnant Women". In this study the investigators will evaluate a new point of care Quantra Hemostasis Analyzer system to assess coagulation rapidly with ease.
What is the current status of trial NCT04301193?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2019-11-01. Estimated completion is 2020-07-31.
What interventions are being tested in trial NCT04301193?
The interventions under investigation include: Quantra Analyzer (DEVICE).
Who is sponsoring clinical trial NCT04301193?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.